BIO's ownership structure stands out with top holders controlling just 0.7% of supply, offering unusual decentralization as the token stabilizes after recent volatility.

Foundation strengthening despite pullback

Despite a roughly

↘35%

monthly decline, BIO outpaced Layer 2 peers by approximately

↗24.58%

over the past year while maintaining exceptionally low ownership concentration at just 0.7%.

Well-distributed ownership reduces risk

With top holders controlling only 0.7% of total supply across 27,926 holders, the ownership structure is well-distributed, reducing the risk of price manipulation by large players.

Trading activity normalizing

Trading volume declined roughly

↘19%

over the past 24 hours as activity stabilizes, while derivatives positioning shows a slightly positive funding rate, suggesting some traders are paying small premiums for bullish positions.